Literature DB >> 3488516

Immunohistochemical analysis of infiltrating lymphocytes in central nervous system tumors.

J T Paine, H Handa, T Yamasaki, J Yamashita, S Miyatake.   

Abstract

To investigate cell-mediated immune responses to central nervous system tumors, we immunohistochemically analyzed 32 operative specimens, including 19 primary tumors, 5 recurrent tumors, and 8 metastases, for the presence of infiltrating T lymphocytes. In 1 patient, an additional sample of normal brain was studied. Using monoclonal antibodies against T lymphocyte surface markers with a peroxidase technique on frozen sections, we determined that a mild lymphocytic response was present in 3 of 7 primary glial tumors, 1 of 4 recurrent glial tumors, and in 3 of 9 primary meningiomas. The predominant subset was Leu 2, or suppressor/cytotoxic. In contrast, 5 of 7 intracranial metastatic tumors and 1 extracranial metastasis showed marked infiltration with an overall Leu 3, or helper/inducer, predominance. The remainder of the specimens, including 1 recurrent meningioma, 3 neurinomas, and the normal brain sample, were free of infiltrates. Permanent sections revealed an overall pattern of lymphocytic infiltration similar to that of frozen sections. Although additional studies such as electron microscopy are required to establish definitively the lymphocytic nature of the infiltrates, these results support the concept of the ability of the body to mount a cell-mediated response against central nervous system tumors and imply a differential response to primary and secondary tumors.

Entities:  

Mesh:

Year:  1986        PMID: 3488516     DOI: 10.1227/00006123-198606000-00015

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  15 in total

1.  Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma.

Authors:  F P Holladay; T Heitz-Turner; W L Bayer; G W Wood
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

2.  Immunophenotypic analysis of infiltrating leukocytes and microglia in an experimental rat glioma.

Authors:  T Morioka; T Baba; K L Black; W J Streit
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes.

Authors:  C D Rice; N G Baldwin; R T Biron; H D Bear; R E Merchant
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

Review 4.  Recent advances in immunobiology of brain tumors.

Authors:  M Tada; N de Tribolet
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

5.  Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation.

Authors:  T Morimura; C Neuchrist; K Kitz; H Budka; O Scheiner; D Kraft; H Lassmann
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Immunohistochemical study of IOT-10 natural killer cells in brain metastases.

Authors:  J Vaquero; S Coca; J Escandón; R Magallón; R Martínez
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

7.  Immune infiltrates and cytokines in gliomas.

Authors:  B Giometto; F Bozza; F Faresin; L Alessio; S Mingrino; B Tavolato
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

8.  Cross-reactivity of monoclonal antibody Leu-19 with some neuroectodermal and other non-immune tissues.

Authors:  R Nawrotzki; A Starzinski-Powitz; F Weber; R Schröder
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 9.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.

Authors:  Gavin P Dunn; Ian F Dunn; William T Curry
Journal:  Cancer Immun       Date:  2007-08-13

10.  Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat.

Authors:  Monica R Hazelrigg; Jerry I Hirsch; Randall E Merchant
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.